Halftime's hottest trades today: 4 trades in 30 seconds. Tearing through Thursday with trades on eBay, GoPro, China's markets, and the semiconductor space.» Read More
Is "Super Tuesday" a new market trend? Paul Hickey, Bespoke Investment Group, says it's really just a coincidence. Hickey also shares his view of the market.
Apple is hitting its highest level since October of 2012 after Carl Icahn said he's still bullish on the company. FMHR trader Dr. J sees a lack of catalysts right now.
CNBC's Meg Tirrell spoke with Merck Chairman & CEO Ken Frazier about the company's decision to sell its over the counter health care products to Bayer.
Shares of Whole Foods have had a rough ride since the company missed its Q1 earnings estimates. FMHR trader Mike Murphy thinks investors should buy the stock now, but FMHR trader Pete Najarian says the stock has "issues."
DoubleLine's Jeff Gundlach is shorting housing through the homebuilder ETF XHB. The FMHR traders share their opinions.
CNBC's Rick Santelli provides perspective on DoubleLine Jeffrey Gundlach's comments on the next direction of yields.
The FMHR traders reveal their final trades.
Carl Icahn cops to a having a "fighting gene"—an observation made by Warren Buffett.
Discussing dominating economic themes, and the action in fixed income, with Jay Bowen, CEO & CIO of Bowen, Hanes & Co.
Sam Isaly of OrbiMed Advisors, provides insight on the health of some of his top health care picks, including Roche Holdings.
Discussing innovation at 3M, and his other industrial stock pick Honeywell, is Jay Bowen, CEO & CIO of Bowen, Hanes & Co.
"Fast Money Halftime Report" trader Stephen Weiss threw the towel in on low-yielding bonds and Softbank.
In an op-ed published in Barron's, Carl Icahn said Warren Buffett was wrong to abstain in the vote over Coca-Cola's executive compensation plan. Carl Icahn speaks to CNBC's Scott Wapner about making CEOs accountable.
Icahn Enterprises' Carl Icahn speaks to CNBC's Scott Wapner about the role and benefit of activism on company boards. He says a "board shouldn't be a country club."
Icahn Enterprises' Carl Icahn says Bill Ackman is "right up there" in trying to change what's going on in American business.
CNBC's Courtney Reagan reports Target CEO Gregg W. Steinhafel's resignation is provoking many questions on Wall Street around the company's health.
Icahn Enterprises' Carl Icahn says Apple CEO Tim Cook is headed in the right direction, and explains why he is not a "short-termist."
Discussing Pfizer's bid for AstraZenaca, and whether his firm will continue to hold its shares, with Sam Isaly of OrbiMed Advisors.
The "Fast Money" traders share their final trades of the day.
From a fiscal perspective, "Things are going pretty well, and I hope we get to play that hand out over the next several years," the CEO says.